Company Details
Overview
Targeted cell-based immunotherapy for cancer treatment.
Total Raised
$4 M
Rounds
2
Links
Verticals
Biotechnology
Clinical Trials
Therapeutics
Investment History
Grant
Oct 2022
$2M
Equity
Jan 2013
$2M
Targeted cell-based immunotherapy for cancer treatment.
Total Raised
$4 M
Rounds
2
Links
Verticals
Grant
Oct 2022
$2M
Equity
Jan 2013
$2M